Menu Close

Trending

Merck makes circular RNA play with $3.5bn Orna alliance
On heels of new data, Gilead pays $455m for Asian Trodelvy rights
Roche eyes April FDA verdict on Polivy as first-line lymphoma therapy
Digital health’s rapid growth spurt comes home to roost
FDA grants swift review to Lynparza in first-line prostate cancer

Richard Jones

Patient journeys in the era of COVID-19

Deep Dive/ Patients/ Views & Analysis/ Views and analysis

Patient journeys in the era of COVID-19

, , , , , 0 Comment

OPEN Health’s Richard Jones and Sumira Riaz assess the pandemic’s implications for understanding patients’ experiences and how the

X
Patient journeys in the era of COVID-19
https://pharmaphorum.com/views-analysis-patients/patient-journeys-in-the-era-of-covid-19/
Delivering change through better rare disease communications

Deep Dive/ R&D/ Views & Analysis/ Views and analysis

Delivering change through better rare disease communications

, , , , , , 0 Comment

OPEN Health’s Richard Jones, Gemma Allen and Charlotte Richards discuss how pharma can utilise tools, channels and stakeholders

X
Delivering change through better rare disease communications
https://pharmaphorum.com/r-d/views-analysis-r-d/delivering-change-through-better-rare-disease-communications/

Login

CONTINUE TO SITE >
X
Close in 10 seconds